- Advertisement -

Wireless smart bandage promotes faster closure of wounds, enhances skin recovery

Some wounds just won't heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months...

Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a...

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

24 August 2021 — Inventia Life Science, together with BioLamina AB, a Swedish biotechnology company leading in matrix biology and cell culture-based research, have...

Equillium to Present at BTIG Virtual Biotechnology Conference 2020 – GlobeNewswire

LA JOLLA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop...

Dartmouth study finds conscious visual perception occurs outside the visual system

Credit: Figure by Sirui Liu and Patrick Cavanagh. A Dartmouth study finds that the conscious perception of...

Cognitive behavioral therapy normalizes brain abnormality in OCD patients

The abnormality also may predict treatment success or failure Credit: UCLA Health FINDINGS UCLA scientists and colleagues studying the...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...

more new items

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent...

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...